Skip to main content

WESPAC Advisors, LLC

SEC CIK
0001484540
Latest filing
Aug 10, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by WESPAC Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q3 2023
Holdings of VRTX by WESPAC Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−670−100.0%Sold outHolders
Q1 2024670$280.1K0.2%00.0%UnchangedHolders
Q4 2023670$272.6K0.2%00.0%UnchangedHolders
Q3 2023670$233.0K0.2%+670NewHolders